Head-to-head comparison
Cora Health vs Kina
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.
$175/mo sema · $225/mo tirz · Verified July 2026
Marked down on: Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
Desk Score
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.
From $179/mo (lowest dose rung) sema · From $179/mo (lowest dose rung) tirz · Verified June 2026
Marked down on: Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
Cora Health takes this head-to-head with the higher Desk Score, 81/100 (B−) against 65/100 (C) for Kina. Kina still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Cora Health
81/100
B−
Kina
65/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Cora Health | Kina |
|---|---|---|
| Semaglutide | $175/mo$175/mo | From $179/molowest dose rung$179/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $225/mo$225/mo | From $179/molowest dose rung$179/mo (starting dose, compounded) |
| Coverage | All 50 states | Not listed on Kina's site (checked June 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure. | Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians. |
| Desk Score | 81/100B− | 65/100C |
The verdict
Desk pick — Cora HealthCora Health takes this head-to-head with the higher Desk Score, 81/100 (B−) against 65/100 (C) for Kina. Kina still holds its ground where its strengths line up with yours.
Choose Cora Health if…
Flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure.
$175/mo sema · $225/mo tirz · All 50 states
Choose Kina if…
Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians.
From $179/mo (lowest dose rung) sema · From $179/mo (lowest dose rung) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Cora Health · Kina.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Cora Health vs CoreAge Rx
- CoreAge Rx vs Kina
- Cora Health vs Trimi
- Kina vs Trimi
- Cora Health vs Elara Health and Wellness
- Elara Health and Wellness vs Kina
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.